H.Res. 242 · 116th Congress
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
- Stage
- In committee
- Sponsor
- G.K. Butterfield
- Introduced
- 2019-03-18
- Latest action
- 2019-03-19 · Referred to the Subcommittee on Health.